AU2002363386A1 - Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins - Google Patents

Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins

Info

Publication number
AU2002363386A1
AU2002363386A1 AU2002363386A AU2002363386A AU2002363386A1 AU 2002363386 A1 AU2002363386 A1 AU 2002363386A1 AU 2002363386 A AU2002363386 A AU 2002363386A AU 2002363386 A AU2002363386 A AU 2002363386A AU 2002363386 A1 AU2002363386 A1 AU 2002363386A1
Authority
AU
Australia
Prior art keywords
medicaments
prevention
appearance
preparation
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002363386A
Other versions
AU2002363386B2 (en
Inventor
Claude Granier
Sylvie Villard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0113360A external-priority patent/FR2830865B1/en
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of AU2002363386A1 publication Critical patent/AU2002363386A1/en
Application granted granted Critical
Publication of AU2002363386B2 publication Critical patent/AU2002363386B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002363386A 2001-10-17 2002-10-17 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins Ceased AU2002363386B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0113360A FR2830865B1 (en) 2001-10-17 2001-10-17 PEPTIDE LURES FOR THE PREPARATION OF MEDICINES FOR THE PREVENTION OR TREATMENT OF AUTOIMMUNE DISEASES, OR OF DISORDERS RELATED TO THE APPEARANCE OF ANTIBODIES DIRECTED AGAINST EXOGENOUS PROTEINS
FR01/13360 2001-10-17
PCT/FR2002/003557 WO2003040176A2 (en) 2001-10-17 2002-10-17 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins

Publications (2)

Publication Number Publication Date
AU2002363386A1 true AU2002363386A1 (en) 2003-07-24
AU2002363386B2 AU2002363386B2 (en) 2009-01-08

Family

ID=8868379

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002363386A Ceased AU2002363386B2 (en) 2001-10-17 2002-10-17 Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins

Country Status (9)

Country Link
US (1) US7632817B2 (en)
EP (1) EP1438330B1 (en)
JP (1) JP2005515177A (en)
AT (1) ATE452139T1 (en)
AU (1) AU2002363386B2 (en)
CA (1) CA2463745A1 (en)
DE (1) DE60234786D1 (en)
FR (1) FR2830865B1 (en)
WO (1) WO2003040176A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110014226A1 (en) * 2008-03-18 2011-01-20 Caulfield Michael J high throughput protein interaction assay
TWI541020B (en) 2008-04-17 2016-07-11 巴克斯歐塔公司 Biologically active peptides

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2473388A (en) * 1987-11-16 1989-06-22 Scripps Clinic And Research Foundation Treatment of factor viii inhibitors
US5187155A (en) * 1989-06-23 1993-02-16 Board Of Regents, The University Of Texas System Anticoagulant peptides
US6180371B1 (en) * 1996-06-26 2001-01-30 Emory University Modified factor VIII
BE1008491A3 (en) * 1994-07-14 1996-05-07 Croix Rouge De Belgique Depart Sequence factor viii polypeptide antigenic, fragments and / or epitopes thereof.
US5846933A (en) * 1996-06-28 1998-12-08 Korngold; Robert CD-4 derived peptides that inhibit immune responses
GB9805913D0 (en) * 1998-03-19 1998-05-13 Kings College University Of Lo Diagnosis of ms
EP1005551A2 (en) * 1997-01-31 2000-06-07 Human Genome Sciences, Inc. Tissue factor pathway inhibitor-3
US6043220A (en) * 1997-12-03 2000-03-28 Intrabiotics Pharmaceuticals, Inc. Threonine-containing protegrins
CA2315537A1 (en) * 1997-12-16 1999-06-24 Regents Of The University Of Minnesota Methods to treat undesirable immune responses
US6197526B1 (en) * 1999-01-04 2001-03-06 Dyax Corp. Polypeptides for binding human factor VIII and fragments of human factor VIII

Similar Documents

Publication Publication Date Title
AU2484399A (en) Controlled release delivery of peptide or protein
EP1329458A3 (en) Peptides that lower blood glucose levels
EP1536828A4 (en) Methods of delivery of exogenous proteins to the cytosol and uses thereof
AU2003214230A8 (en) High protein concentrate from corn and methods of preparation thereof
WO2002059143A3 (en) Therapeutic peptides for demyelinating conditions
AU2003267532A1 (en) PEPTIDES AND PEPTIDE DERIVATIVES FOR THE TREATMENT OF Alpha-SYNUCLEIN-RELATED DISEASES
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
WO2001014395A3 (en) Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof
AU2002300166A1 (en) Process for the Preparation of Peptides
AU2001249214A1 (en) Suppression of vascular disorders by mucosal administration of heat shock protein peptides
GB0031489D0 (en) Light delivery system for improving the appearance of skin
AU2002363386A1 (en) Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU7508100A (en) Human seizure related proteins
WO2003055440A8 (en) Compositions and methods for the treatement of immune related diseases
AU2002342858A1 (en) Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
AU2003295435A1 (en) Biological carriers for the delivery of proteins or peptides
AU2002364757A1 (en) Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases
WO2003040176A3 (en) Peptide decoys for the preparation of medicaments that are intended for the prevention or treatment of autoimmune pathologies or problems linked to the appearance of antibodies directed against exogenous proteins
AU2002308267A1 (en) Regulation of human icos v protein
WO2001016319A3 (en) Compositions and methods for the treatment of immune related diseases
AU2002365148A1 (en) Human ras interacting protein
AU2002215956A1 (en) Regulation of human pgc-1-like protein
AU2002231620A1 (en) Regulation of human patched-like protein
AU3902600A (en) Compositions and methods for the treatment of immune related diseases